Healthcare perspectives from The Economist Intelligence Unit

Color

#DB444B

Hero Carousel

Spotlight

Bringing healthcare to hard-hit areas in Bangladesh

YouTube

https://www.youtube.com/channel/UCQDMOSbJtqrtNzif5rS22OQ

Slideshare

http://www.slideshare.net/economistintelligenceunit

Pinterest

https://www.pinterest.com/theeiu/

Women’s health and well-being


How do definitions of women’s well-being vary by region, age and income? Our new infographic, sponsored by Merck Consumer Health explores.

One stripe at a time: raising awareness of rare diseases in Latin America

RDs are a group of poorly understood, predominantly heritable disorders that often manifest in childhood and have a significant impact on quality of life and life expectancy. RDs are not uncommon. There are between 6,000-8,000 RDs, which affect approximately 350-450m people globally. In Latin America alone, roughly 40-50m people are affected by a RD.

Biopharma’s evolution: learnings from the pandemic for a revived regulatory landscape

By December 2020, several potential covid-19 vaccines were showing promise in clinical trials. And by the middle of 2021, a vaccine was available to the public. Very few people had been optimistic that such a feat could be achieved. In many ways, it was a perfect storm. The fast development of covid-19 vaccines benefited from years of previous research on related viruses and vaccine trials that used mRNA. It’s said the research matured at just the right time, and that mRNA technology would not have been ready even five years ago.

The longevity equation: climate resilience for health in the Middle East

Climate change is one of the most complex threats to the health of our people and our planet. The Middle East is among the geographic areas most vulnerable to rising temperatures, air pollution, food and water insecurity and adverse weather events. Without considerable mitigation and adaptation efforts, the health and longevity of current and future generations will be severely impacted.

 

Musculoskeletal Injuries in Australia: Current Challenges and Opportunities

Musculoskeletal disorders (MSDs), affecting an estimated 1.71 billion people globally, are a leading cause of disability and rehabilitation needs, accounting for 149 million years lived with disability.1

The longevity equation: climate resilience for health in the Middle East

Climate change is one of the most complex threats to the health of our people and our planet. The Middle East is among the geographic areas most vulnerable to rising temperatures, air pollution, food and water insecurity and adverse weather events. Without considerable mitigation and adaptation efforts, the health and longevity of current and future generations will be severely impacted.

 

Tackling the challenges of antimicrobial resistance (AMR) in Africa

In the heart of the bustling Nigerian city of Lagos, under the relentless sun, stands a small pharmacy with a faded green sign. It’s a modest place, just a short walk away from my childhood home. As a child, I often wandered inside, not for sweets or toys, but in pursuit of something far more valuable—health.

Tackling antimicrobial resistance in healthcare: the significance of robust health and economic data

Antimicrobial resistance (AMR) ranks among the top ten global public health challenges.1 Partly driven by the inappropriate and injudicious use of antimicrobial agents, AMR poses a significant threat.

Universal health, rare diseases and the promise of the UN Resolution

On an individual basis, rare diseases (RDs) can affect relatively small numbers of people. Collectively, however, they wage a significant burden—there are over 7,000 RDs and together they affect 300m people globally. The impact of RDs extends beyond their prevalence, stunting economic development the world over; although evidence on the economic burden in Europe is scarce, to provide perspective, in the US the annual costs of 15.5m people with 379 RDs equates to over US$1trn, with inpatient care and prescription medications driving 50% of total direct costs (US$449bn).

Unmasking the risk and burden of seasonal influenza in the Middle East: Strengthening prevention and control strategies for a healthier tomorrow

Seasonal influenza is a major cause of morbidity and mortality worldwide. Annually, the respiratory virus infects approximately one billion people, resulting in severe illness in up to five million cases, and is responsible for up to 650,000 deaths.Influenza affects all countries, communities and individuals with those at the extremes of the age spectrum, and those with underlying chronic health conditions, being the most vulnerable to influenza and its resulting complications. 

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week